Plain-English translation of NCT07182656 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is a Phase 1 trial testing a new medication called CIGB-814, which is given by injection. Researchers are studying whether the medication is safe and how the body processes it when given as single or repeated doses. The trial will eventually help determine if this treatment could be useful for people with rheumatoid arthritis.
Before any new medication can be tested in patients with a disease, researchers must first confirm it is safe in healthy people. This study is the earliest step in that process, designed to identify any side effects and understand how the body absorbs and uses this medication.
You likely qualify if…
You likely don't qualify if…
Participants will receive either the new medication or a placebo (inactive substance) by injection, either as a single dose or as multiple doses over time. The study involves visits where researchers will take blood samples, monitor vital signs, and ask about any side effects or symptoms. The entire study lasts several weeks, and participants will be monitored closely to ensure the medication is safe.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
China